-
[show abstract]
[hide abstract]
ABSTRACT: Since publication of the human genome in 2003, geneticists have been interested in risk variant associations to resolve the etiology of traits and complex diseases. The International HapMap Consortium undertook an effort to catalog all common variation across the genome (variants with a minor allele frequency (MAF) of at least 5% in one or more ethnic groups). HapMap along with advances in genotyping technology led to genome-wide association studies which have identified common variants associated with many traits and diseases. In 2008 the 1000 Genomes Project aimed to sequence 2500 individuals and identify rare variants and 99% of variants with a MAF of <1%.
To determine whether the 1000 Genomes Project includes all the variants in HapMap, we examined the overlap between single nucleotide polymorphisms (SNPs) genotyped in the two resources using merged phase II/III HapMap data and low coverage pilot data from 1000 Genomes.
Comparison of the two data sets showed that approximately 72% of HapMap SNPs were also found in 1000 Genomes Project pilot data. After filtering out HapMap variants with a MAF of <5% (separately for each population), 99% of HapMap SNPs were found in 1000 Genomes data.
Not all variants cataloged in HapMap are also cataloged in 1000 Genomes. This could affect decisions about which resource to use for SNP queries, rare variant validation, or imputation. Both the HapMap and 1000 Genomes Project databases are useful resources for human genetics, but it is important to understand the assumptions made and filtering strategies employed by these projects.
Journal of the American Medical Informatics Association 03/2012; 19(2):289-94. · 3.61 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: In the analysis of large-scale genomic datasets, an important consideration is the power of analytical methods to identify accurate predictive models of disease. When trying to assess sensitivity from such analytical methods, a confounding factor up to this point has been the presence of linkage disequilibrium (LD). In this study, we examined the effect of LD on the sensitivity of the Multifactor Dimensionality Reduction (MDR) software package.
Four relative amounts of LD were simulated in multiple one- and two-locus scenarios for which the position of the functional SNP(s) within LD blocks varied. Simulated data was analyzed with MDR to determine the sensitivity of the method in different contexts, where the sensitivity of the method was gauged as the number of times out of 100 that the method identifies the correct one- or two-locus model as the best overall model. As the amount of LD increases, the sensitivity of MDR to detect the correct functional SNP drops but the sensitivity to detect the disease signal and find an indirect association increases.
Higher levels of LD begin to confound the MDR algorithm and lead to a drop in sensitivity with respect to the identification of a direct association; it does not, however, affect the ability to detect indirect association. Careful examination of the solution models generated by MDR reveals that MDR can identify loci in the correct LD block; though it is not always the functional SNP. As such, the results of MDR analysis in datasets with LD should be carefully examined to consider the underlying LD structure of the dataset.
BioData Mining 01/2011; 4:11.
-
[show abstract]
[hide abstract]
ABSTRACT: Personalized medicine is a high priority for the future of health care. The idea of tailoring an individual's wellness plan to their unique genetic code is one which we hope to realize through the use of pharmacogenomics. There have been examples of tremendous success in pharmacogenomic associations however there are many such examples in which only a small proportion of trait variance has been explained by the genetic variation. Although the increased use of GWAS could help explain more of this variation, it is likely that a significant proportion of the genetic architecture of these pharmacogenomic traits are due to complex genetic effects such as epistasis, also known as gene-gene interactions, as well as gene-drug interactions. In this study, we utilize the Biofilter software package to look for candidate epistasis contributing to risk for virologic failure with efavirenz-containing antiretroviral therapy (ART) regimens in treatment-naïve participants of AIDS Clinical Trials Group (ACTG) randomized clinical trials. A total of 904 individuals from three ACTG trials with data on efavirenz treatment are analyzed after race-stratification into white, black, and Hispanic ethnic groups. Biofilter was run considering 245 candidate ADME (absorption, distribution, metabolism, and excretion) genes and using database knowledge of gene and protein interaction networks to produce approximately 2 million SNP-SNP interaction models within each ethnic group. These models were evaluated within the PLATO software package using pair wise logistic regression models. Although no interaction model remained significant after correction for multiple comparisons, an interaction between SNPs in the TAP1 and ABCC9 genes was one of the top models before correction. The TAP1 protein is responsible for intracellular transport of antigen to MHC class I molecules, while ABCC9 codes for a transporter which is part of the subfamily of ABC transporters associated with multi-drug resistance. This study demonstrates the utility of the Biofilter method to prioritize the search for gene-gene interactions in large-scale genomic datasets, although replication in a larger cohort is required to confirm the validity of this particular TAP1-ABCC9 finding.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 01/2011;
-
[show abstract]
[hide abstract]
ABSTRACT: Genome Wide Association Studies (GWAS) are a standard approach for large-scale common variation characterization and for identification of single loci predisposing to disease. However, due to issues of moderate sample sizes and particularly multiple testing correction, many variants of smaller effect size are not detected within a single allele analysis framework. Thus, small main effects and potential epistatic effects are not consistently observed in GWAS using standard analytical approaches that consider only single SNP alleles. Here, we propose unique methodology that aggregates variants of interest (for example, genes in a biological pathway) using GWAS results. Multiple testing and type I error concerns are minimized using empirical genomic randomization to estimate significance. Randomization corrects for common pathway-based analysis biases, such as SNP coverage and density, linkage disequilibrium, gene size and pathway size. Pathway Analysis by Randomization Incorporating Structure (PARIS) applies this randomization and in doing so directly accounts for linkage disequilibrium effects. PARIS is independent of association analysis method and is thus applicable to GWAS datasets of all study designs. Using the KEGG database as an example, we apply PARIS to the publicly available Autism Genetic Resource Exchange GWAS dataset, revealing pathways with a significant enrichment of positive association results.
Human Genetics 01/2011; 129(5):563-71. · 5.07 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The initial presentation of multifactor dimensionality reduction (MDR) featured cross-validation to mitigate over-fitting, computationally efficient searches of the epistatic model space, and variable construction with constructive induction to alleviate the curse of dimensionality. However, the method was unable to differentiate association signals arising from true interactions from those due to independent main effects at individual loci. This issue leads to problems in inference and interpretability for the results from MDR and the family-based compliment the MDR-pedigree disequilibrium test (PDT). A suggestion from previous work was to fit regression models post hoc to specifically evaluate the null hypothesis of no interaction for MDR or MDR-PDT models. We demonstrate with simulation that fitting a regression model on the same data as that analyzed by MDR or MDR-PDT is not a valid test of interaction. This is likely to be true for any other procedure that searches for models, and then performs an uncorrected test for interaction. We also show with simulation that when strong main effects are present and the null hypothesis of no interaction is true, that MDR and MDR-PDT reject at far greater than the nominal rate. We also provide a valid regression-based permutation test procedure that specifically tests the null hypothesis of no interaction, and does not reject the null when only main effects are present. The regression-based permutation test implemented here conducts a valid test of interaction after a search for multilocus models, and can be applied to any method that conducts a search to find a multilocus model representing an interaction.
PLoS ONE 01/2010; 5(2):e9363. · 4.09 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Whole-genome association (WGA) studies are becoming a common tool for the exploration of the genetic components of common disease. The analysis of such large scale data presents unique analytical challenges, including problems of multiple testing, correlated independent variables, and large multivariate model spaces. These issues have prompted the development of novel computational approaches. Thorough, extensive simulation studies are a necessity for methods development work to evaluate the power and validity of novel approaches. Many data simulation packages exist, however, the resulting data is often overly simplistic and does not compare to the complexity of real data; especially with respect to linkage disequilibrium (LD). To overcome this limitation, we have developed genomeSIMLA. GenomeSIMLA is a forward-time population simulation method that can simulate realistic patterns of LD in both family-based and case-control datasets. In this manuscript, we demonstrate how LD patterns of the simulated data change under different population growth curve parameter initialization settings. These results provide guidelines to simulate WGA datasets whose properties resemble the HapMap.
Lecture Notes in Computer Science 01/2008; 4973(2008):24-35.
-
[show abstract]
[hide abstract]
ABSTRACT: The identification of susceptibility genes for common, chronic disease presents great challenges. The development of novel statistical and computational methodologies to help identify these genes is an area of great necessity. Much research is ongoing and the Genetic Analysis Workshop (GAW) is a venue for the dissemination and comparison of many of these methods. GAW15 included real data sets to look for disease susceptibility genes for rheumatoid arthritis (RA). RA is a complex, chronic inflammatory disease with several replicated disease genes, but much of the genetic variation in the phenotype remains unexplained. We applied two computational methods, namely multifactor dimensionality reduction (MDR) and grammatical evolution neural networks (GENN), to three data sets from GAW15. While these analytic methods were applied with the intention of detecting of multilocus models of association, both methods identified a strong single locus effect of a single-nucleotide polymorphism (SNP) in PTPN22 that is significantly associated with RA. This SNP has previously been associated with RA in several other published studies. These results demonstrate that both MDR and GENN are capable of identifying a single-locus main effect, in addition to multilocus models of association. This is the first published comparison of the two methods. Because GENN employs an evolutionary computation search strategy in comparison to the exhaustive search strategy of MDR, it is encouraging that the two methods produced similar results. This comparison should be extended in future studies with both simulated and real data.
BMC proceedings 02/2007; 1 Suppl 1:S70.
